|
Q3 FY2026
As of Jun 28, 2026
|
Q2 FY2026
As of Mar 29, 2026
|
Q1 FY2026
As of Dec 28, 2025
|
Q4 FY2025
As of Sep 28, 2025
|
Q3 FY2025
As of Jun 29, 2025
|
Q2 FY2025
As of Mar 30, 2025
|
Q1 FY2025
As of Dec 29, 2024
|
Q4 FY2024
As of Sep 29, 2024
|
Q3 FY2024
As of Jun 23, 2024
|
Q2 FY2024
As of Mar 24, 2024
|
Q1 FY2024
As of Dec 24, 2023
|
Q4 FY2023
As of Sep 24, 2023
|
Q3 FY2023
As of Jun 25, 2023
|
Q2 FY2023
As of Mar 26, 2023
|
Q1 FY2023
As of Dec 25, 2022
|
Q4 FY2022
As of Sep 25, 2022
|
Q3 FY2022
As of Jun 26, 2022
|
Q2 FY2022
As of Mar 27, 2022
|
Q1 FY2022
As of Dec 26, 2021
|
Q4 FY2021
As of Sep 26, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Held for sale assets | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Held for sale assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade accounts payable | ||||||||||||||||||||
| Payroll and other benefits related liabilities | ||||||||||||||||||||
| Unearned revenues | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Held for sale liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Unearned revenues | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Held for sale liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding | ||||||||||||||||||||
| Preferred stock, par value | ||||||||||||||||||||
| Preferred stock, shares authorized | ||||||||||||||||||||
| Preferred stock, shares outstanding | ||||||||||||||||||||
| Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,057 and 1,074 shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock, par value | ||||||||||||||||||||
| Common stock, shares authorized | ||||||||||||||||||||
| Common stock, shares, issued | ||||||||||||||||||||
| Common stock, shares, outstanding | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
